More than one half of Russians stated that they would not purchase COVID-19 medicines if they were costly, according to a survey conducted in the fourth quarter of 2020. Furthermore, approximately 45 percent held the view that such products should be available to purchase only with a prescription.
Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Number of consumers of pharmaceutical drugs in Italy 2010-2022
- Basic Statistic Number of users of antidepressants in Norway 2009-2020, by gender
- Basic Statistic U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Basic Statistic Prescription items dispensed in England 2022, by therapeutic class
- Basic Statistic Leading bronchodilators dispensed in England 2022, by item number
- Basic Statistic Leading antidepressant drugs dispensed in England by item number 2022
- Basic Statistic Leading antianginal drugs dispensed in England 2022, by item number
- Basic Statistic Leading 10 analgesic drugs dispensed in England 2022, by item
- Premium Statistic Availability of new medicines in Europe in 2023, by country
- Basic Statistic Expenditure on nonprescription pharmaceuticals in Sweden 2009-2022
About the region
10
- Premium Statistic Most popular medications in Russia 2022, by sales value
- Premium Statistic Inflation on pharmaceuticals in Russia 2008-2022
- Premium Statistic Pharmaceutical production value in Russia 2015-2022
- Premium Statistic Pharmaceutical production volume in Russia 2015-2022
- Premium Statistic Chemicals and pharma revenue by segment Russia 2021
- Premium Statistic Chemicals and pharma export value by segment Russia 2021
- Premium Statistic Chemicals and pharma import value by segment Russia 2021
- Premium Statistic Chemicals and pharma consumption in Russia 2021, by segment
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Premium Statistic Pharma e-commerce sales value growth in Russia 2020, by product
Selected statistics
4
Other regions
10
- Basic Statistic Rate of return on biopharma R&D late stage pipeline 2013-2022
- Basic Statistic YTD stock performance of biopharma companies working on COVID March 2020
- Premium Statistic Sales share of Novo Nordisk's drugs in Chinese diabetes market 2021, by segment
- Premium Statistic OTC medicines: change in sales value in Great Britain 2012-2013, by category
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Mexico: pharmaceutical expenditure 2012-2018
- Basic Statistic Illinois' medical cannabis sales value U.S. 2018-2024
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
Related statistics
10
- Premium Statistic Readiness to order OTC pharma online in Russia 2020, by city size
- Premium Statistic Share of pharmaceutical customers in Russia 2018-2019, by age
- Premium Statistic Share of Russians purchasing medications 2019, by type
- Premium Statistic Chemicals and pharma revenue share in Russia in 2017, by segment
- Premium Statistic Leading online pharmacies in Russia 2023, by number of orders
- Premium Statistic Average order value in e-pharmacies in Russia 2023, by platform
- Premium Statistic Chemicals and pharmaceuticals production growth in Russia 2017-2022
- Premium Statistic Most downloaded pharmacy apps in Russia 2023
- Premium Statistic Online pharmacy market revenue in Russia 2018-2022
- Premium Statistic Online pharmacy average order value in Russia 2018-2022
Further related statistics
9
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co total assets 2009-2023
- Pfizer's ad spending 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
Further Content: You might find this interesting as well
Statistics
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co total assets 2009-2023
- Pfizer's ad spending 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
DSM Group. (March 1, 2021). Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement [Graph]. In Statista. Retrieved April 26, 2024, from https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/
DSM Group. "Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement." Chart. March 1, 2021. Statista. Accessed April 26, 2024. https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/
DSM Group. (2021). Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement. Statista. Statista Inc.. Accessed: April 26, 2024. https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/
DSM Group. "Opinion on Medication against The Coronavirus (Covid-19) in Russia in 4th Quarter 2020, by Statement." Statista, Statista Inc., 1 Mar 2021, https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/
DSM Group, Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement Statista, https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/ (last visited April 26, 2024)
Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement [Graph], DSM Group, March 1, 2021. [Online]. Available: https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/